Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK Trading as: Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Resonium A.
| Pharmaceutical Form |
|---|
|
Buff coloured powder. |
Contains Sodium Polystyrene Sulfonate 99.934% w/w.
| Active Ingredient | Description | |
|---|---|---|
| Polystyrene sulfonate |
|
| List of Excipients |
|---|
|
Resonium A also contains: saccharin and vanillin. |
Supplied in HDPE containers with LDPE tamper evident closures containing 454g Resonium A together with a plastic scoop, which, when filled level, contains approximately 15g.
Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Trading as:
Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
PL 04425/0178
2 April 2003
| Drug | Countries | |
|---|---|---|
| RESONIUM | Austria, Australia, Finland, Hong Kong, Netherlands, New Zealand, Poland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
